Chemical maker DuPont agrees to $27M settlement in polluted water lawsuit in upstate New York
HOOSICK FALLS, N.Y. — Chemical maker DuPont has agreed to a US$27 million settlement to resolve a nearly decade-long lawsuit over the contamination of an upstate New York village's water supply.
The deal was announced Wednesday by lawyers representing residents of Hoosick Falls, located northwest of Albany, just as the case was headed to trial in federal court this week.
The settlement brings the total recovered in the class action suit brought in 2016 to more than $90 million, lawyers for Rochester-based firm Faraci Lange said.
Three other companies — Saint-Gobain Performance Plastics, Honeywell International and 3M —settled for a total of more than $65 million in 2021. DuPont was the last remaining defendant.
'We are gratified to have reached what we believe will be the final resolution of this case that will provide significant added benefit to the residents of Hoosick Falls and the Town of Hoosick,' said Stephen Schwarz.
A spokesperson for Delaware-based DuPont didn't immediately respond to an email seeking comment Friday.
The DuPont settlement, which must still be approved by a federal judge, also includes another $6 million in funding for an existing medical monitoring program for exposed residents, according to attorneys.
In their class action suit, Hoosick Falls residents claimed that a local Teflon fabric coating facility operated by Saint-Gobain and Honeywell caused local drinking water to become contaminated with perfluorooctanoic acid, or PFOA.
DuPont, which made Teflon materials used at the facility, and 3M, which made the PFOA used by DuPont in its products, were added as defendants to the lawsuit in 2018.
PFOA was once widely used in certain industrial processes but is now considered a harmful 'forever chemical' because it can persist in the environment for decades without decomposing.
It has been linked to a number of serious illnesses including kidney and testicular cancer and has recently been classified as a carcinogen.
The Associated Press
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
3 hours ago
- Globe and Mail
3 Absurdly Cheap Growth Stocks to Load Up On Right Now
Key Points Novo Nordisk, PayPal, and Dell Technologies are modestly priced growth stocks with a lot of potential to rise higher. They all trade at forward price-to-earnings multiples of 17 or less. 10 stocks we like better than Novo Nordisk › Buying stocks that are trading at cheap valuations can set you up for some big gains later on. And it can minimize the risk of a decline if the market starts to struggle. Although many stocks look expensive today, there are three growth stocks which still seem absurdly cheap right now: Novo Nordisk (NYSE: NVO), PayPal (NASDAQ: PYPL), and Dell Technologies (NYSE: DELL). By investing in these companies, you can gain exposure to some top businesses, while also diversifying your portfolio. Here's a closer look at why each of these stocks can be a good long-term investment. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » Novo Nordisk Drugmaker Novo Nordisk is a terrific healthcare company to consider investing in. The market has been bearish on it over the past year, as recent results from clinical trials haven't met expectations; there are also new concerns that tariffs on pharmaceuticals may weigh down Novo Nordisk and similar stocks. But as concerning as these developments may be, they're also short-term in nature. Novo Nordisk has been a growth-focused business for decades, and some solid products in its portfolio, including Wegovy and Ozempic, have enabled it to generate strong results in recent quarters and put it on track for even more growth in the future. Through the first three months of the year, the company grew its sales by 19% and its operating profit by 22%. The company is a big-name player in the market for GLP-1 medications. And if you invest in it today, you can get it for a modest forward price-to-earnings (P/E) multiple of 17. That's based on analyst estimates, but it gives you a good idea of how cheap the stock is -- the average stock in the S&P 500 trades at a forward P/E of 24. With its encouraging growth prospects, Novo Nordisk could be a no-brainer buy at its current valuation. PayPal A fintech company that doesn't seem to get enough love these days is PayPal. There are certainly concerns that growing competition will chip away at its growth, but its payment platform remains a top choice for customers and vendors to rely on. Its share of the global payments market remains at 45%, making it the top option, despite a flurry of other ways to pay. The company also has its own stablecoin, PayPal USD, so it can potentially leverage opportunities in the crypto space. Growth has been underwhelming of late, as sales through the first three months of the year totaled $7.8 billion, an increase of just 1% year over year. However, the economy is contending with rising costs and tariffs, so consumers scaling back on spending may have more to do with that slowdown than anything PayPal is doing. It's far too early to count PayPal out as a top growth stock: There's still a lot of room for it to grow, especially with PayPal USD in the mix, and its Venmo app is rising in popularity as well. At a forward P/E of only 15, this is an even cheaper stock to own than Novo Nordisk. Dell Technologies Computer maker Dell Technologies isn't doing well with the consumer market this year, but sales of servers have been strong, especially as companies invest heavily in artificial intelligence (AI). For its current fiscal year (which ends in January), Dell projects that its AI server sales will top $15 billion, an increase from the $10 billion total in the previous year. Dell is well positioned to take advantage of AI trends both in the business market and in the consumer market, through the sales of AI computers and servers. While sales of AI computers aren't taking off just yet, it may only be a matter of time before an upgrade cycle takes place, especially as consumers look to take advantage of next-gen computing capabilities. In its most recent quarter, which ended on May 2, Dell's revenue rose by a modest 5% to $23.4 billion. But if not for a 19% decline in its consumer segment, those numbers would have been much better. Dell is a trusted computer manufacturer and it's doing well, even if its operations aren't firing on all cylinders. At a forward P/E of less than 14, this is the cheapest stock on this list. With loads of potential in AI and other computing, Dell may be one of the better growth stocks to buy right now. Should you invest $1,000 in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,477!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,010,880!* Now, it's worth noting Stock Advisor 's total average return is1,047% — a market-crushing outperformance compared to180%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 14, 2025 David Jagielski has positions in Novo Nordisk. The Motley Fool has positions in and recommends PayPal. The Motley Fool recommends Novo Nordisk and recommends the following options: long January 2027 $42.50 calls on PayPal and short June 2025 $77.50 calls on PayPal. The Motley Fool has a disclosure policy.
CBC
11 hours ago
- CBC
Investigator issues recommendations after delayed gov't response to lead in school water
An independent investigation found lengthy delays in the N.W.T. government's response to detecting lead in the drinking water of some schools, because two of its departments failed to understand the health implications of the situation. Jocelyn Shepel has more.
Globe and Mail
11 hours ago
- Globe and Mail
Dr. Joel Durinka Scholarship for Future Doctors Announces Inaugural Call for Applications
Fostering Academic Excellence and Visionary Leadership in Aspiring Medical Professionals Nationwide from Philadelphia, PA Buffalo, NY - The Dr. Joel Durinka Scholarship for Future Doctors proudly announces its inaugural call for applications, offering a significant opportunity for undergraduate students across the United States who are committed to pursuing careers in medicine. Established by the esteemed physician and educator, Dr. Joel Durinka, this scholarship underscores a profound dedication to cultivating the next generation of healthcare leaders. Based in Philadelphia, PA, this initiative aims to identify and support students who demonstrate exceptional academic promise and a clear vision for making a positive impact on the healthcare field. Fostering Medical Excellence and Impact The Dr. Joel Durinka Scholarship for Future Doctors is designed to alleviate financial burdens for aspiring physicians, enabling them to focus on their rigorous academic and professional development. This scholarship reflects Dr. Joel Durinka's unwavering commitment to medical education and his belief in the transformative power of dedicated healthcare professionals. The program seeks individuals who not only excel academically but also possess a deep-seated passion for patient care and a clear understanding of how they intend to contribute meaningfully to the evolving landscape of medicine. The scholarship is a testament to the importance of investing in future medical talent, ensuring that compassionate and skilled physicians are ready to meet the challenges of tomorrow's healthcare needs. Eligibility and Application Requirements Prospective applicants for the Dr. Joel Durinka Scholarship for Future Doctors must meet stringent criteria to be considered. Eligible candidates are undergraduate students currently enrolled in an accredited college or university within the United States. A fundamental requirement is a clear intent to pursue a career as a physician. Academic excellence is paramount, with applicants needing to maintain a minimum GPA of 3.0. The application process culminates in the submission of a comprehensive application form alongside a compelling 500-800-word essay. The essay prompt challenges applicants to articulate their profound motivation for entering the medical field, outline their strategies for creating a positive impact on healthcare, and explain how this scholarship will be instrumental in achieving their aspirations as future physicians. A Commitment to Nurturing Talent The evaluation process for the Dr. Joel Durinka Scholarship for Future Doctors is holistic, focusing on several key areas. Applications are meticulously reviewed based on academic achievement, ensuring that recipients demonstrate a strong foundation for medical studies. The clarity of career goals is another critical component, as the scholarship seeks individuals with a well-defined path and purpose. A genuine passion for medicine, evident in their experiences and aspirations, is highly valued. Ultimately, the quality and depth of the essay submission play a pivotal role, serving as a window into the applicant's commitment, vision, and potential to contribute significantly to the medical profession. This comprehensive approach ensures that the scholarship identifies deserving students who are truly poised to make a difference. Key Dates and Award Details The Dr. Joel Durinka Scholarship for Future Doctors offers a one-time award of $1,000 to the selected recipient. This financial assistance is intended to provide crucial support as students navigate the demanding journey toward becoming a physician. The application window is now open, with a firm deadline of April 15, 2026. All submissions must be received by this date to be considered. Following a thorough review process, the scholarship winner will be officially announced on May 15, 2026. Aspiring medical students nationwide are encouraged to visit the official scholarship website for detailed application instructions and to submit their materials well in advance of the deadline. A Vision from Dr. Joel Durinka "Establishing the Dr. Joel Durinka Scholarship for Future Doctors is a profound privilege," states Dr. Joel Durinka. "My career has been dedicated to patient care and the advancement of medical knowledge, and I believe it is essential to support the next generation who share this commitment. This scholarship is more than just financial aid; it is an investment in the future of healthcare. I am eager to see the innovative ideas and profound dedication that applicants will bring forward, and I look forward to supporting a student who will undoubtedly make a significant positive impact on the lives of countless individuals through their medical practice." About The Dr. Joel Durinka Scholarship for Future Doctors The Dr. Joel Durinka Scholarship for Future Doctors is a philanthropic initiative dedicated to supporting promising undergraduate students across the United States who are pursuing careers in medicine. Founded by Dr. Joel Durinka, the scholarship aims to foster academic excellence, promote visionary leadership, and encourage impactful contributions within the healthcare field. It provides financial assistance to help alleviate the costs associated with medical education, ensuring that talented and passionate students can achieve their aspirations of becoming physicians. About Dr. Joel Durinka Dr. Joel Durinka is a distinguished physician, educator, and mentor recognized for his significant contributions to medicine and community service. His extensive academic background and diverse medical training reflect a deep-seated dedication to the healthcare profession. Through the Dr. Joel Durinka Scholarship for Future Doctors, he extends his commitment to nurturing and guiding the next generation of medical professionals, reinforcing the importance of education and mentorship in shaping the future of healthcare. Media Contact Company Name: Dr. Joel Durinka Scholarship Contact Person: Dr. Joel Durinka Email: Send Email City: Buffalo State: NY Country: United States Website:
